pharma · Colorectal Cancer · Esophageal Varices in NASH Cirrhosis · GALT
Galectin Therapeutics
GALECTIN THERAPEUTICS INC
Galectin Therapeutics clinical programs — 12 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 4960 Peachtree Industrial Boulevard, Suite 240, Norcross, GA 30071, US
- Founded
- 2000
- Employees
- 36
- Programs
- 12
- Drugs
- 5
- Patents
- 20
Galectin Therapeutics projects
12 ClinicalTrials.gov programs sponsored by Galectin Therapeutics.
Galectin Therapeutics has 12 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Placebo of BELAPECTIN, BELAPECTIN
GALECTIN THERAPEUTICS INC
Esophageal Varices in NASH Cirrhosis
1 trial -
belapectin
GALECTIN THERAPEUTICS INC
Prevention of Esophageal Varices
1 trial -
GM-CT-01
GALECTIN THERAPEUTICS INC
Cancer of the Bile Duct
1 trial -
GM-CT-01
GALECTIN THERAPEUTICS INC
Colorectal Cancer
2 trials -
GM-CT-01 plus 5-Fluorouracil
GALECTIN THERAPEUTICS INC
Colorectal Cancer
1 trial -
GR-MD-02
GALECTIN THERAPEUTICS INC
Hypertension, Portal
1 trial -
GR-MD-02
GALECTIN THERAPEUTICS INC
Nonalcoholic Steatohepatitis
1 trial -
GR-MD-02
GALECTIN THERAPEUTICS INC
Psoriasis
1 trial -
1 mg/kg GR-MD-02
GALECTIN THERAPEUTICS INC
Metastatic Melanoma
1 trial -
GR-MD-02
GALECTIN THERAPEUTICS INC
Non-Alcoholic Steatohepatitis (NASH)
1 trial -
GR-MD-02
GALECTIN THERAPEUTICS INC
Melanoma
1 trial -
belapectin
GALECTIN THERAPEUTICS INC
Hepatic Impairment
1 trial
Frequently asked questions
How many clinical projects does Galectin Therapeutics have?
12 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.